Viral Hepatitis Other than A, B, or C

2016 ◽  
Author(s):  
Nadeem Anwar ◽  
Kenneth E. Sherman
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis Virus ◽  
Cell Damage ◽  
Hepatitis E ◽  
Hepatitis D ◽  
Hepatitis D Virus ◽  
Treatment And Prevention ◽  
Key Words Hepatitis

Viral hepatitis is a global, although variably distributed, health problem associated with significant morbidity and mortality. Infection with a hepatitis virus leads to acute inflammation and liver cell damage (hepatocyte injury). Such infection may be symptomatic or subclinical and may result in disease resolution, death from fulminant hepatic failure, or development of  a chronic disease state. Whereas the chronic infection with hepatitis B and C accounts for a global burden of more than 500,000,000 cases, the global death rate from all types of hepatitis is approximately 1 million people annually. This review focuses on the virology, epidemiology, clinical features, diagnosis, treatment, and prevention of hepatitis D and hepatitis E, as well as other viruses associated with hepatitis. Figures show the global distribution of hepatitis D infection, elevation of anti–hepatitis D virus antibodies in hepatitis B/hepatitis D virus coinfection, geographic distribution of hepatitis E virus by genotype, factors significant in the pathogenesis of hepatitis E, and pattern of antibody elevation in hepatitis E. The table lists proposed diagnostic criteria for hepatitis E virus. This review contains 5 highly rendered figures, 1 table, and 42 references. Key words: hepatitis D, hepatitis D virus, hepatitis E, hepatitis E virus, non-A hepatitis, non-B hepatitis, non-C hepatitis, viral hepatitis 

Viral Hepatitis Other than A, B, or C

2016 ◽  
Author(s):  
Nadeem Anwar ◽  
Kenneth E. Sherman
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis Virus ◽  
Cell Damage ◽  
Hepatitis E ◽  
Hepatitis D ◽  
Hepatitis D Virus ◽  
Treatment And Prevention ◽  
Key Words Hepatitis

Viral hepatitis is a global, although variably distributed, health problem associated with significant morbidity and mortality. Infection with a hepatitis virus leads to acute inflammation and liver cell damage (hepatocyte injury). Such infection may be symptomatic or subclinical and may result in disease resolution, death from fulminant hepatic failure, or development of  a chronic disease state. Whereas the chronic infection with hepatitis B and C accounts for a global burden of more than 500,000,000 cases, the global death rate from all types of hepatitis is approximately 1 million people annually. This review focuses on the virology, epidemiology, clinical features, diagnosis, treatment, and prevention of hepatitis D and hepatitis E, as well as other viruses associated with hepatitis. Figures show the global distribution of hepatitis D infection, elevation of anti–hepatitis D virus antibodies in hepatitis B/hepatitis D virus coinfection, geographic distribution of hepatitis E virus by genotype, factors significant in the pathogenesis of hepatitis E, and pattern of antibody elevation in hepatitis E. The table lists proposed diagnostic criteria for hepatitis E virus. This review contains 5 highly rendered figures, 1 table, and 42 references. Key words: hepatitis D, hepatitis D virus, hepatitis E, hepatitis E virus, non-A hepatitis, non-B hepatitis, non-C hepatitis, viral hepatitis 

Viral Hepatitis Other Than A, B, or C

2016 ◽  
Author(s):  
Nadeem Anwar ◽  
Kenneth E. Sherman
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis Virus ◽  
Cell Damage ◽  
Hepatitis E ◽  
Hepatitis D ◽  
Hepatitis D Virus ◽  
Treatment And Prevention ◽  
Key Words Hepatitis

Viral hepatitis is a global, although variably distributed, health problem associated with significant morbidity and mortality. Infection with a hepatitis virus leads to acute inflammation and liver cell damage (hepatocyte injury). Such infection may be symptomatic or subclinical and may result in disease resolution, death from fulminant hepatic failure, or development of  a chronic disease state. Whereas the chronic infection with hepatitis B and C accounts for a global burden of more than 500,000,000 cases, the global death rate from all types of hepatitis is approximately 1 million people annually. This review focuses on the virology, epidemiology, clinical features, diagnosis, treatment, and prevention of hepatitis D and hepatitis E, as well as other viruses associated with hepatitis. Figures show the global distribution of hepatitis D infection, elevation of anti–hepatitis D virus antibodies in hepatitis B/hepatitis D virus coinfection, geographic distribution of hepatitis E virus by genotype, factors significant in the pathogenesis of hepatitis E, and pattern of antibody elevation in hepatitis E. The table lists proposed diagnostic criteria for hepatitis E virus. This review contains 5 highly rendered figures, 1 table, and 42 references. Key words: hepatitis D, hepatitis D virus, hepatitis E, hepatitis E virus, non-A hepatitis, non-B hepatitis, non-C hepatitis, viral hepatitis 

scholarly journals Biochemical Parameters in Common Viral Hepatitis

1970 ◽  
Vol 11 (1) ◽  
pp. 42-45 ◽  
Author(s):  
Md Ashraf-Uz-Zaman ◽  
Bilquis Ara Begum ◽  
Humaira Binte Asad ◽  
Shafia Sharmin Moutoshi ◽  
Md Nasiruddin
Keyword(s):  
Hepatitis C ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Biochemical Parameters ◽  
Hepatitis A ◽  
Serum Alkaline Phosphatase ◽  
Hepatitis E ◽  
Mean Value ◽  
Serum Bilirubin Level ◽  
Hepatitis D

Viral hepatitis is the inflammation of the liver caused by hepatitis viruses. The most common causes of viral hepatitis are the five unrelated hepatotropic viruses Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Hepatitis E. The aim of this study is to assess the biochemical parameters in viral hepatitis which varies with respect to the different types of viral hepatitis. Sex of the patient affected by Hepatitis A was almost similar in male and female, being 9 (45%) and 11 (55%) in respectively. But in contrast, more than eighty per cent (85%) Hepatitis-E affected population was male. Similar scenario was found in Hepatitis B And C infection (Male- 75%,67%, Female 25,35%). Mean value with standard deviation (±SD) of serum bilirubin level was highest in Hepatitis E (251 ± 125.19 ìmol/l). Value of serum ALT in hepatitis E was found to be 1794 U/l (highest), hepatitis B 1362 U/l hepatitis C are 135.45 U/L,. Serum aspartate aminotransferase (S.AST) is also raised in all types of vira hepatitis but more in Hepatitis E (765 U/l) and Hepatitis B (430 U/l). Serum Alkaline Phosphatase (ALP) was raised significantly in Hepatitis B (240 U/l). The prothombin time was more altered in Hepatitis-E (22.7seconds) and Hepatitis-B (18.5 seconds). There was no significant alteration in serum protein level. So, it can be concluded that derangement of biochemical parameters in patients suffering from common types of viral hepatitis is more in HEV and HBV and comparatively less in HAV and HCV. Keywords: Viral hepatitis, hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E DOI:10.3329/jom.v11i1.4268 J Medicine 2010: 11: 42-45

Viral Hepatitis: A, B, C, D and E—Infection

1992 ◽  
Vol 13 (6) ◽  
pp. 203-212
Author(s):  
Saul Krugman
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Venereal Disease ◽  
Hepatitis E ◽  
Infectious Hepatitis ◽  
Yellow Fever Vaccine ◽  
Hepatitis D ◽  
Varicella Zoster ◽  
Barr Virus

Viral hepatitis is caused by at least five etiologically and immunologically distinct viruses: hepatitis A (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and hepatitis E (HEV). The clinical, epidemiologic, and immunologic features of these five forms of viral hepatitis may be similar or different. Hepatitis also may occur during the course of disease caused by cytomegalovirus, Epstein-Barr virus, herpes simplex virus, varicella-zoster virus, adenoviruses, enteroviruses, rubella virus, arboviruses, and other agents. Hepatitis A is synonymous with "infectious hepatitis," an ancient disease described by Hippocrates and formerly known as epidemic jaundice, acute catarrhal jaundice, and other designations. The fulminant form of the disease was called acute yellow atrophy of the liver. Hepatitis B is synonymous with "serum hepatitis," a disease with a more recent history. The first known outbreak occurred during 1883 among a group of shipyard workers who were vaccinated against smallpox with glycerinated lymph of human origin. Later, an increased incidence of the disease was observed among patients attending venereal disease clinics, diabetes clinics, and other facilities where multiple injections were given with inadequately sterilized syringes and needles contaminated with the blood of a viral carrier. The most extensive outbreak occured in 1942, when yellow fever vaccine containing human serum caused 28 585 cases of hepatitis B infection with jaundice among United Stated military personnel.

Hepatitis A to E

2020 ◽  
pp. 3108-3119
Author(s):  
Graeme J.M. Alexander ◽  
Kate Nash
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Chronic Infection ◽  
Hepatitis A ◽  
Hepatitis E ◽  
Chronic Viral Hepatitis ◽  
Hepatitis D ◽  
Immunoglobulin Preparations ◽  
Hepatitis B Immunoglobulin ◽  
Polymerase Chain

The clinical picture with each of the five major hepatitis viruses A, B, C, D, and E depends firstly upon whether infection is acute, with resolution, or evolves into chronic infection; secondly, on the grade of hepatic inflammation; and thirdly, the stage of fibrosis. Acute icteric hepatitis is the most easily recognized consequence of infection and is generally a self-limited condition. In otherwise healthy individuals, only hepatitis B and C cause chronic viral hepatitis. In immunosuppressed individuals, hepatitis A can follow a protracted course, while hepatitis E can evolve to chronic infection. A specific diagnosis is made by the combination of serology and polymerase chain reaction. Uncomplicated cases recover spontaneously; there is no proven therapy to enhance recovery. Acute liver failure caused by viral hepatitis now has a good outcome, with liver transplantation available for those with poor parameters at onset. Protection against hepatitis A and B is available, both by active vaccination and (less often now) by passive administration of hepatitis B immunoglobulin preparations. Vaccines for hepatitis C are some distance away, but for hepatitis E are under investigation. Vaccination against hepatitis B also protects against hepatitis D.

scholarly journals Seroprevalence and Co-infection of Hepatitis A and Hepatitis E Viruses in children - A hospital-based study in Bangladesh

2021 ◽  
Vol 8 (2) ◽  
pp. 1-5
Author(s):  
Bodhrun Naher ◽  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Hepatitis E ◽  
Virus Hepatitis ◽  
Hepatitis D ◽  
B Virus

Viral hepatitis is a serious health problem globally and in endemic countries like Bangladesh. Viral hepatitis may present as mono-infection or co-infection caused by Hepatitis A Virus (HAV), hepatitis B virus, hepatitis C virus, hepatitis D virus, and Hepatitis E Virus (HEV)

scholarly journals Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Mohammad Amin Behzadi ◽  
Victor Hugo Leyva-Grado ◽  
Mandana Namayandeh ◽  
Atoosa Ziyaeyan ◽  
Roya Feyznezhad ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Hepatitis Virus ◽  
Public Health Problem ◽  
Global Public Health ◽  
Hepatitis D ◽  
Hbs Ag ◽  
Viral Hepatitis A

Abstract Background Viral hepatitis is a global public health problem affecting millions of people worldwide, causing thousands of deaths due to acute and persistent infection, cirrhosis, and liver cancer. Providing updated serologic data can improve both surveillance and disease control programs. This study is aimed to determine the seroprevalence of markers for viral hepatitis (A, B, C, D and E) and the epidemiology of such infections in the general population of southern Iran’s Hormozgan province. Methods Between 2016 and 2017, a total of 562 individuals with ages ranging from 1 to 86 years, who visited governmental public laboratories for routine check-ups, were tested for the presence of serological markers to hepatitis virus types A to E using enzyme-linked immunosorbent assays. Results The overall anti-hepatitis A virus (HAV) antibody seroprevalence was 93.2% (524/562). The prevalence of anti-hepatitis E virus (HEV) antibodies was 15.8% (89/562) among which 1.6% (9/562) of the seropositive individuals also had evidence of recent exposure to the virus (IgM positivity). Two and a half percent (14/562) were positive for hepatitis B surface (HBs) antigen, whereas 11.6% (65/562) tested positive for anti-hepatitis B core (HBc) antibodies. Among anti-HBc positive patients, 11% (7/65) had HBs Ag and 5% (3/65) were positive for anti-hepatitis D virus (HDV) antibodies. The prevalence of anti-hepatitis C virus (HCV) antibodies was 0.7% (4/562). The seroprevalence of anti-HAV, HEV IgG, anti-HBc antibodies, and HBs Ag increased with age. Conclusion The present study confirms a high seroprevalence of HAV infection among the examined population and reveals high levels of endemicity for HEV in the region. Planned vaccination policies against HAV should be considered in all parts of Iran. In addition, improvements on public sanitation and hygiene management of drinking water sources for the studied area are recommended.

scholarly journals Foetal outcome in pregnancy complicated with viral hepatitis

2017 ◽  
Vol 6 (5) ◽  
pp. 2073
Author(s):  
Harshada S. Thakur ◽  
Niranjan Maydeo ◽  
Madhuri Kamble
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Common Cause ◽  
B Virus ◽  
Foetal Outcome ◽  
Nicu Admission ◽  
In Pregnancy

Background: The purpose of this study is to study foetal outcome in pregnancy complicated with viral hepatitis, rate of NICU admission and foetal death.Methods: This is a cross sectional observational study undertaken in the Department of Obstetrics and Gynaecology at the tertiary care centre for the study period from October 2015 to October 2016 approved by ethical committee.Results: There were 6555 deliveries in study period of October 2015-2016 in which 54 patients were diagnosed with viral hepatitis in pregnancy. Out of 54 patients of viral hepatitis, 30 cases (55.55%) of Hepatitis E virus, 22 cases (40.74%) of Hepatitis B virus, 2 cases (3.7%) of Hepatitis C virus. No case was found for Hepatitis A virus infection. Higher incidence of NICU admission (56.66%), preterm delivery (36.66%) and intra uterine death (23.33%) was observed with Hepatitis E infection.Conclusions: Foetal outcome was poor in Hepatitis E virus followed by Hepatitis B virus. Acute viral hepatitis is more common cause of hepatitis in pregnancy. Hepatitis E virus was the most common cause of acute infection with adverse fetal outcome. Fetal loss including intra uterine death and preterm neonate was statistically significant with Hepatitis E viral infection. Health education, early diagnosis and multidisciplinary approach is the key to reduce foetal morbidity and mortality. As HBV infection in hepatitis in pregnancy is second most common cause of viral hepatitis, complete immunization against HBV in reproductive age group before first pregnancy is recommended.

Sign in / Sign up

Export Citation Format

Share Document